Elevance Health Inc
ELV435.070USD
+3.070+0.71%
Handelsschluss 03/31, 16:00（ET）Kurse um 15 Minuten verzögert
98.97BMarktkapitalisierung
16.55KGV TTM
mehr Informationen über Elevance Health Inc Unternehmen
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
Unternehmensinformationen
Unternehmens-codeELV
Name des UnternehmensElevance Health Inc
IPO-datumOct 30, 2001
Gegründet am2001
CEOMs. Gail K. Boudreaux
Anzahl der mitarbeiter103158
WertpapierartOrdinary Share
GeschäftsjahresendeOct 30
Addresse220 Virginia Avenue
StadtINDIANAPOLIS
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl46204
Telefon18003311476
Websitehttps://www.elevancehealth.com/
Unternehmens-codeELV
IPO-datumOct 30, 2001
Gegründet am2001
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Gail K. Boudreaux
Ms. Gail K. Boudreaux
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
149.75K
+11.80%
Mr. Blair Williams Todt
Mr. Blair Williams Todt
Executive Vice President and Chief Legal and Administrative Officer
Executive Vice President and Chief Legal and Administrative Officer
18.59K
-2.10%
Ms Elizabeth E Tallett
Ms Elizabeth E Tallett
Independent Chairman of the Board
Independent Chairman of the Board
10.29K
--
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Director
Independent Director
8.74K
--
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.32K
--
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.19K
--
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
1.69K
+3.99%
Ms. Deanna D. Strable-Soethout
Ms. Deanna D. Strable-Soethout
Independent Director
Independent Director
1.04K
--
Mr. Charles M. Kendrick, Jr.
Mr. Charles M. Kendrick, Jr.
Executive Vice President and President, Commercial & Specialty Health Benefits
Executive Vice President and President, Commercial & Specialty Health Benefits
--
--
Mr. Robert L. Dixon, Jr.
Mr. Robert L. Dixon, Jr.
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Gail K. Boudreaux
Ms. Gail K. Boudreaux
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
149.75K
+11.80%
Mr. Blair Williams Todt
Mr. Blair Williams Todt
Executive Vice President and Chief Legal and Administrative Officer
Executive Vice President and Chief Legal and Administrative Officer
18.59K
-2.10%
Ms Elizabeth E Tallett
Ms Elizabeth E Tallett
Independent Chairman of the Board
Independent Chairman of the Board
10.29K
--
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Director
Independent Director
8.74K
--
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.32K
--
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.19K
--
Umsatzaufteilung
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Premiums
144.17B
0.00%
Product revenue
22.63B
0.00%
Service fees
8.41B
0.00%
Reconciliation
1.81B
0.00%
Operating revenue - affliated
0.00
0.00%
Keine Daten
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Premiums
144.17B
0.00%
Product revenue
22.63B
0.00%
Service fees
8.41B
0.00%
Reconciliation
1.81B
0.00%
Operating revenue - affliated
0.00
0.00%
Aktionäre
Update-Zeit: Fri, Feb 21
Update-Zeit: Fri, Feb 21
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
The Vanguard Group, Inc.
9.41%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Global Advisors (US)
4.70%
T. Rowe Price Associates, Inc.
4.50%
Wellington Management Company, LLP
2.80%
Other
73.42%
Aktionärsstatistik
Aktionäre
Anteil
The Vanguard Group, Inc.
9.41%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Global Advisors (US)
4.70%
T. Rowe Price Associates, Inc.
4.50%
Wellington Management Company, LLP
2.80%
Other
73.42%
Art
Aktionäre
Anteil
Investment Advisor
41.36%
Investment Advisor/Hedge Fund
40.80%
Pension Fund
2.63%
Hedge Fund
2.61%
Bank and Trust
2.49%
Research Firm
1.80%
Sovereign Wealth Fund
1.45%
Family Office
0.27%
Family Office
0.27%
Other
6.32%
Institutionelle Beteiligung
Update-Zeit: Sun, Jan 19
Update-Zeit: Sun, Jan 19
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
2997
212.97M
91.83%
-5.51M
2024Q4
3098
213.30M
93.78%
-5.08M
2024Q3
3004
212.78M
91.75%
-6.27M
2024Q2
2973
214.50M
92.28%
-4.31M
2024Q1
2940
212.64M
91.38%
-6.83M
2023Q4
2879
214.42M
91.26%
-6.60M
2023Q3
2767
215.95M
91.62%
-5.63M
2023Q2
2750
218.40M
92.12%
-4.32M
2023Q1
2729
219.91M
92.66%
-8.42M
2022Q4
2684
220.86M
92.46%
-8.53M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
21.38M
9.41%
+141.85K
+0.67%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
11.78M
5.18%
+200.94K
+1.74%
Dec 31, 2024
State Street Global Advisors (US)
10.68M
4.7%
-5.71K
-0.05%
Dec 31, 2024
T. Rowe Price Associates, Inc.
10.24M
4.5%
+459.21K
+4.70%
Dec 31, 2024
Wellington Management Company, LLP
6.36M
2.8%
+1.89M
+42.45%
Dec 31, 2024
Geode Capital Management, L.L.C.
4.96M
2.18%
+115.97K
+2.39%
Dec 31, 2024
Sanders Capital, LLC
4.69M
2.06%
+76.90K
+1.67%
Dec 31, 2024
Capital International Investors
3.88M
1.71%
+35.58K
+0.93%
Dec 31, 2024
First Eagle Investment Management, L.L.C.
3.23M
1.42%
+1.04M
+47.56%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
3.08M
1.35%
+28.53K
+0.94%
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Update-Zeit: Thu, Mar 6
Update-Zeit: Thu, Mar 6
Name
Anteil
iShares U.S. Healthcare Providers ETF
11.08%
Monarch Dividend Plus Index ETF
5.58%
VictoryShares Free Cash Flow ETF
3.13%
GMO US Quality ETF
3.1%
Simplify Market Neutral Equity Long/Short ETF
3.07%
NYLI Healthy Hearts ETF
2.78%
Eagle Capital Select Equity ETF
2.62%
FT Cboe Vest Rising Dividend Achievers Target Inc
2.46%
First Trust Rising Dividend Achievers ETF
2.08%
iShares Large Cap Active ETF
2.07%
Mehr Anzeigen
iShares U.S. Healthcare Providers ETF
Anteil11.08%
Monarch Dividend Plus Index ETF
Anteil5.58%
VictoryShares Free Cash Flow ETF
Anteil3.13%
GMO US Quality ETF
Anteil3.1%
Simplify Market Neutral Equity Long/Short ETF
Anteil3.07%
NYLI Healthy Hearts ETF
Anteil2.78%
Eagle Capital Select Equity ETF
Anteil2.62%
FT Cboe Vest Rising Dividend Achievers Target Inc
Anteil2.46%
First Trust Rising Dividend Achievers ETF
Anteil2.08%
iShares Large Cap Active ETF
Anteil2.07%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
6.19B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Jan 23, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Mar 25, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 25, 2025
Mar 10, 2025
Oct 17, 2024
ELV.NB Final Cash Dividend of gross USD 1.63 paid on Dec 20, 2024 going ex on Dec 05, 2024
Dec 05, 2024
Dec 20, 2024
Dec 05, 2024
Jul 17, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Sep 25, 2024 going ex on Sep 10, 2024
Sep 10, 2024
Sep 25, 2024
Sep 10, 2024
Apr 18, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Jun 25, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 25, 2024
Jun 10, 2024
Jan 26, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Mar 22, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 22, 2024
Mar 07, 2024
Oct 18, 2023
ELV.NB Final Cash Dividend of gross USD 1.48 paid on Dec 21, 2023 going ex on Dec 05, 2023
Dec 06, 2023
Dec 21, 2023
Dec 05, 2023
Jul 19, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Sep 22, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 22, 2023
Sep 07, 2023
Apr 19, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Jun 23, 2023 going ex on Jun 08, 2023
Jun 09, 2023
Jun 23, 2023
Jun 08, 2023
Jan 25, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Mar 24, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 24, 2023
Mar 09, 2023
Oct 19, 2022
ELV.NB Final Cash Dividend of gross USD 1.28 paid on Dec 21, 2022 going ex on Dec 02, 2022
Dec 05, 2022
Dec 21, 2022
Dec 02, 2022
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten